Company OverviewNovamind
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.
Speaker BioChief Medical Officer & Director
Novamind
Dr. Reid Robison is a board-certified psychiatrist who was named Best Psychiatrist in Utah by Salt Lake City Weekly’s Best of Utah Body & Mind 2020. Dr. Robison is the co-founder of Cedar Psychiatry and serves as the Medical Director for the Center for Change, a leading Eating Disorder center.
He is currently the coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders. As an early adopter and researcher of ketamine in psychiatry, Dr. Robison led a pivotal IV ketamine study for treatment-resistant depression by Janssen, leading up to the company’s recent FDA-approval of Spravato™. To date, Dr. Robison has guided thousands of ketamine therapy journeys and hundreds of Spravato™ dosing sessions. As a social entrepreneur, Dr. Robison has built a number of purpose-driven companies including Tute Genomics which was acquired by PierianDx in 2016.
Dr. Robison is also an adjunct professor at both the University of Utah and Brigham Young University and is the founder of the Polizzi Free Clinic, a free mental health clinic for marginalized people based in Salt Lake City, Utah.
Speaker BioCEO, Director, & Co-Founder
Novamind
Yaron Conforti is an entrepreneur and the principal of EmmCap Corp., an investor in venture-stage companies. EmmCap actively participates in its early-stage investments via board and management roles. Yaron has over 20 years of venture capital investing and operating experience, including founder and CEO roles in companies across different industries. Past EmmCap investments include Abacus Health Products (acquired by Charlotte’s Web), GR Silver Mining (TSXV:GRSL),IM Cannabis (NASDAQ:IMCC) and Enveric Biosciences (NASDAQ:ENVB). Yaron previously served in senior investment banking roles at Desjardins Securities and Sandfire Securities where he focused on micro/small cap equities.
